Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-0587
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2017
Authors
Publisher
American Association for Cancer Research (AACR)